Internal Inflammation/Innate Immunity Programs
Undisclosed inflammatory/immune-mediated diseases
Pre-clinicalActive
Key Facts
Indication
Undisclosed inflammatory/immune-mediated diseases
Phase
Pre-clinical
Status
Active
Company
About Synovo
Synovo GmbH is a private, pre-clinical stage biotechnology company leveraging its interdisciplinary expertise in pharmacology, medicinal chemistry, and bioanalytics. The company pursues a hybrid strategy, generating revenue through contract research services while advancing an internal pipeline targeting inflammation and innate immunity. With a team of nearly 50 specialists and a strong network of global research partners, Synovo aims to translate scientific insight into novel therapeutic options for unmet medical needs.
View full company profile